🕵️ Sangamo Therapeutics, Inc ($SGMO)
SEC insider & ownership activity, last 12 months · CIK 1001233 · every row links its SEC filing
Over the last 12 months insiders sold $107K with no open-market buying against it. Dubois-Stringfellow Nathalie sold $89K in discretionary trades (Apr). 5 red-flag 8-Ks in the window, most recently Bankruptcy (1.03), Jul 14, 2026.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 2 sellers, $107K (2 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Dubois-Stringfellow Nathalie | 0 | – | 1 | $89K | Apr 21, 2026 |
| Gregory D. Davis | 0 | – | 1 | $18K | Apr 22, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 9.8% | 13G | May 15, 2026 | filing ↗ | |
| Steven Boyd | 9.8% | 13G | May 15, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Gregory D Davis | $18K | Apr 22, 2026 | filing ↗ |
| Nathalie Dubois-Stringfellow | $177K | Apr 6, 2026 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Bankruptcy (1.03) | Jul 14, 2026 | filing ↗ |
| Delisting notice (3.01) | Jul 14, 2026 | filing ↗ |
| Auditor change (4.01) | Jun 24, 2026 | filing ↗ |
| Other events (8.01) | Jun 24, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 24, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 18, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 18, 2026 | filing ↗ |
| Bankruptcy (1.03) | Jun 18, 2026 | filing ↗ |
| New financial obligation (2.03) | Jun 18, 2026 | filing ↗ |
| Exit or disposal costs (2.05) | Jun 18, 2026 | filing ↗ |
| Earnings (2.02) | May 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 14, 2026 | filing ↗ |
| Delisting notice (3.01) | Apr 28, 2026 | filing ↗ |
| Earnings (2.02) | Mar 30, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 30, 2026 | filing ↗ |
| Material agreement (1.01) | Feb 3, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Feb 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 3, 2026 | filing ↗ |
| Other events (8.01) | Feb 3, 2026 | filing ↗ |
| Earnings (2.02) | Feb 2, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 2, 2026 | filing ↗ |
| Earnings (2.02) | Nov 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 6, 2025 | filing ↗ |
| Delisting notice (3.01) | Oct 29, 2025 | filing ↗ |
| Officer/director changes (5.02) | Sep 24, 2025 | filing ↗ |
| Officer/director changes (5.02) | Sep 9, 2025 | filing ↗ |
| Other events (8.01) | Sep 4, 2025 | filing ↗ |
| Earnings (2.02) | Aug 7, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 7, 2025 | filing ↗ |